张铁寒, 刘斌. 肿瘤合并卡氏肺孢子菌肺炎1例[J]. 武警医学, 2024, 35(3): 237-240.
ZHANG Tiehan, LIU Bin. One case of tumor complicated with pneumocystis carinii pneumonia. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(3): 237-240.
Mecoli A,Danoff K.Pneumocystis jirovecii pneumonia and other infections in idiopathic inflammatory myositis[J].Curr Rheumatol Rep,2020,22(2):7-19.
[1]
Liu Y,Su L,Jiang S J,et al.Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis[J]. Oncotarget,2017, 8(35):59729-59739.
[7]
Nureki S I,Usagawa Y,Watanabe E,et al.Veno-venous extracorporeal membrane oxygenation for severe pneumocystis ijrovecii pneumonia in an immunocompromised patient without HIV infection[J].Tohoku J Exp Med,2020,250(4):215-221.
[2]
Fishman J A.Pneumocystis jiroveci[J].Semin Respir Crit Care Med,2020,41(1):141-157.
[8]
Liu C J,Lee TF,Ruan S Y,et al.Clinical characteristics,treatment outcomes,and prognostic factors of pneumocystis pneumonia in non-HIV-infected patients[J].Infect Drug Resist,2019,12:1457-1467.
[3]
Edman J C,Kovacs J A,Masur H,et al.Ribosomal RNA sequence shows pneumocystis carinii to be a member of the fungi[J]. Nature, 1988,334(6182):519-522.
[9]
Mu X D,Jia P,Gao L,et al.Relationship between radiological stages and prognoses of pneumocystis pneumonia in non-aids immunocompromised patients[J]. Chin Med J (Engl),2016,129(17):2020-2025.
Rogina P,Skvarc M.Diagnostic accuracy of (1-->3)-beta-D-glucan to predict pneumocystis jirovecii pneumonia in non-HIV-infected patients[J].Radiol Oncol,2020,54(2):221-226.
[5]
Martinez A,Halliez M C,Aliouat M,et al.Growth and airborne transmission of cell-sorted life cycle stages of pneumocystis carinii[J]. PLoS One,2013,8(11):423.
[11]
Zhang Y,Ai J W,Cui P,et al.A cluster of cases of pneumocystis pneumonia identified by shotgun metagenomics approach[J].J Infect,2019,78(2):158-169.
[6]
Mecoli A,Danoff K.Pneumocystis jirovecii pneumonia and other infections in idiopathic inflammatory myositis[J].Curr Rheumatol Rep,2020,22(2):7-19.
Nureki S I,Usagawa Y,Watanabe E,et al.Veno-venous extracorporeal membrane oxygenation for severe pneumocystis ijrovecii pneumonia in an immunocompromised patient without HIV infection[J].Tohoku J Exp Med,2020,250(4):215-221.
Liu C J,Lee TF,Ruan S Y,et al.Clinical characteristics,treatment outcomes,and prognostic factors of pneumocystis pneumonia in non-HIV-infected patients[J].Infect Drug Resist,2019,12:1457-1467.
[14]
Zhang F,Chen J,Huang H,et al.Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients[J].Eur J Clin Microbiol Infect Dis,2021,40 ( 9):1933-1942.
[9]
Mu X D,Jia P,Gao L,et al.Relationship between radiological stages and prognoses of pneumocystis pneumonia in non-aids immunocompromised patients[J]. Chin Med J (Engl),2016,129(17):2020-2025.
[15]
Tasaka S.Recent advances in the diagnosis and management of pneumocystis pneumonia[J]. Tuberc Res Dis,2020,83(2):132-140.
[10]
Rogina P,Skvarc M.Diagnostic accuracy of (1-->3)-beta-D-glucan to predict pneumocystis jirovecii pneumonia in non-HIV-infected patients[J].Radiol Oncol,2020,54(2):221-226.
[16]
White P L,Price J S,Backx M.Therapy and management of pneumocystis jirovecii infection[J].J Fungi,2018,4(4):127.
[11]
Zhang Y,Ai J W,Cui P,et al.A cluster of cases of pneumocystis pneumonia identified by shotgun metagenomics approach[J].J Infect,2019,78(2):158-169.
[17]
Nakashima K,Aoshima M,Nakashita T,et al.Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: a single-center retrospective observational cohort study[J]. J Microbiol Immunol Infect,2018,51(6):810-820.
Mundo W,Morales S L,Tewaha S,et al.Lower mortality associated with adjuvant corticosteroid therapy in non-HIV-infected patients with pneumonia:a single-institution retrospective US cohort study[J]. Open Forum Infect Dis,2020,7(9):ofaa354.
[14]
Zhang F,Chen J,Huang H,et al.Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients[J].Eur J Clin Microbiol Infect Dis,2021,40 ( 9):1933-1942.
[20]
Pareja J G, Garland R, Koziel H.Use of adjunctive corticosteroids in severe adult non-HIV pneumocystis carinii pneumonia[J]. Chest,1998,113(5):1215-1224.
[15]
Tasaka S.Recent advances in the diagnosis and management of pneumocystis pneumonia[J]. Tuberc Res Dis,2020,83(2):132-140.
[16]
White P L,Price J S,Backx M.Therapy and management of pneumocystis jirovecii infection[J].J Fungi,2018,4(4):127.
[17]
Nakashima K,Aoshima M,Nakashita T,et al.Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: a single-center retrospective observational cohort study[J]. J Microbiol Immunol Infect,2018,51(6):810-820.
[18]
Nevez G,Le G S.Caspofungin and pneumocystis pneumonia: it is time to go ahead[J]. Antimicrob Agents Chemother,2019,63(10):456.
[19]
Mundo W,Morales S L,Tewaha S,et al.Lower mortality associated with adjuvant corticosteroid therapy in non-HIV-infected patients with pneumonia:a single-institution retrospective US cohort study[J]. Open Forum Infect Dis,2020,7(9):ofaa354.
[20]
Pareja J G, Garland R, Koziel H.Use of adjunctive corticosteroids in severe adult non-HIV pneumocystis carinii pneumonia[J]. Chest,1998,113(5):1215-1224.
2024, Vol. 35 
